Aligos Therapeutics, Inc.

The current price of ALGS is 0.7870 USD — it has decreased by 5.75% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Aligos Therapeutics, Inc. stocks are traded under the ticker ALGS.

Aligos Therapeutics, Inc. is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.

ALGS stock is 7.45% volatile and has beta coefficient of 2.34. Check out the list of the most volatile stocks — is Aligos Therapeutics, Inc. there?

One year price forecast for Aligos Therapeutics, Inc. has a max estimate of 7.0000 USD and a min estimate of 1.0000 USD.

ALGS earnings for the last quarter are −0.41 USD whereas the estimation was −0.48 USD which accounts for 13.68% surprise. Estimated earnings for the next quarter are −0.28 USD. See more details about Aligos Therapeutics, Inc. earnings.

Aligos Therapeutics, Inc. revenue for the last quarter amounts to ‪2.15 M‬ USD despite the estimated figure of ‪2.50 M‬ USD. In the next quarter revenue is expected to reach ‪1.60 M‬ USD.

ALGS stock has fallen by 25.05% compared to the previous week, the month change is a 13.52% fall, over the last year Aligos Therapeutics, Inc. has showed a 18.02% decrease.

No, ALGS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, ALGS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Aligos Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.

ALGS reached its all-time high on Jan 20, 2021 with the price of 37.5099 USD, and its all-time low was 0.5388 USD and was reached on Oct 24, 2023.
See other stocks reaching their highest and lowest prices.

As of Apr 18, 2024, the company has 66.00 employees. See our rating of the largest employees — is Aligos Therapeutics, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Aligos Therapeutics, Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Aligos Therapeutics, Inc. stock shows the sell signal. See more of Aligos Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on Aligos Therapeutics, Inc. future price: according to them, ALGS price has a max estimate of 7.00 USD and a min estimate of 1.00 USD. Read a more detailed Aligos Therapeutics, Inc. forecast: see what analysts think of Aligos Therapeutics, Inc. and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Aligos Therapeutics, Inc. EBITDA is ‪−85.06 M‬ USD, and current EBITDA margin is −543.23%. See more stats in Aligos Therapeutics, Inc. financial statements.